What are the limitations of using AI for medical lab analysis?

While AI can help interpret lab results and identify patterns, it lacks medical context, cannot replace professional diagnosis, and may miss nuanced health conditions. For comprehensive analysis, specialized health AI platforms designed for biomarker interpretation offer better accuracy than general-purpose AI tools.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The promise and reality of AI in healthcare

Artificial intelligence has revolutionized many aspects of healthcare, from drug discovery to medical imaging. When it comes to analyzing lab results, AI tools promise to make complex medical data more accessible and understandable. However, the reality is more nuanced than the marketing suggests.

While AI can process vast amounts of data and identify patterns humans might miss, using it for medical lab analysis comes with significant limitations that users need to understand. These constraints range from technical issues to fundamental questions about medical decision-making and patient safety.

Lack of comprehensive medical context

Missing patient history and medications

One of the most critical limitations of AI lab analysis is the lack of complete medical context. General AI tools typically analyze lab results in isolation, without access to your full medical history, current medications, or existing conditions. This missing context can lead to misinterpretation of results that might be perfectly normal for your specific situation.

For example, certain medications can affect liver enzyme levels, making them appear elevated when they're actually within expected ranges for someone on that treatment. Without knowing about your prescriptions, an AI might flag these as concerning when they're not. Similarly, chronic conditions can alter baseline values for various biomarkers, making standard reference ranges less applicable.

Inability to consider symptoms and physical findings

Lab results are just one piece of the diagnostic puzzle. A comprehensive medical evaluation includes physical examination findings, symptom patterns, and clinical observations that AI cannot access. A slightly elevated inflammatory marker might be insignificant in an asymptomatic person but could be crucial in someone experiencing specific symptoms.

Technical and accuracy limitations

Training data biases and limitations

AI models are only as good as the data they're trained on. Many AI systems are trained on datasets that may not represent diverse populations adequately, leading to potential biases in interpretation. Reference ranges can vary significantly based on age, sex, ethnicity, and geographic location, but not all AI systems account for these variations appropriately.

Additionally, rare conditions or unusual presentations might not be well-represented in training data, causing AI to miss or misinterpret important findings. This is particularly concerning for patients with uncommon genetic variations or those from underrepresented populations.

Inability to detect data quality issues

AI systems typically assume the lab data they're analyzing is accurate, but various factors can affect result quality. Pre-analytical errors like improper sample collection, storage issues, or timing problems can significantly impact results. While experienced clinicians might recognize when results don't make clinical sense, AI systems often lack this intuitive quality control.

For instance, a hemolyzed blood sample might produce falsely elevated potassium levels. A human reviewer familiar with the patient's history might question this result and request a repeat test, while an AI might simply interpret it at face value.

Regulatory and legal constraints

Diagnostic limitations and liability

Most AI tools for lab analysis are explicitly not approved for diagnostic purposes by regulatory bodies like the FDA. They're designed to provide educational information rather than medical diagnoses. This distinction is crucial because it means the AI cannot and should not be making definitive statements about your health conditions.

The legal implications of AI-based medical advice remain largely untested. Questions about liability when AI provides incorrect interpretations or misses critical findings create additional limitations on how these tools can be used responsibly in healthcare settings.

Privacy and data security concerns

Using general-purpose AI tools for medical data analysis raises significant privacy concerns. Many AI platforms store and potentially use uploaded data for model training or other purposes. Medical lab results contain highly sensitive personal health information that requires strict protection under laws like HIPAA.

Without proper safeguards and compliance measures, using consumer AI tools for lab analysis could expose your health data to unauthorized access or use. This is why specialized health platforms with proper security measures and compliance certifications offer a safer alternative for analyzing sensitive medical data.

Interpretation and communication challenges

Oversimplification of complex results

Medical lab results often involve complex interactions between multiple biomarkers. AI systems may oversimplify these relationships or fail to recognize important patterns that require nuanced interpretation. For example, thyroid function involves multiple hormones that must be interpreted together, considering feedback loops and individual variations.

The tendency to provide binary 'normal' or 'abnormal' classifications can miss the subtleties of borderline results or trends over time. A result that's technically within normal range but has changed significantly from previous tests might be clinically important, but basic AI interpretation might miss this context.

Risk of false reassurance or unnecessary anxiety

AI interpretations can create two problematic scenarios: false reassurance when results are labeled as normal despite clinical concerns, or unnecessary anxiety when minor variations are flagged as abnormal. Without the ability to provide proper context or consider individual circumstances, AI tools may cause more confusion than clarity.

This is particularly problematic for screening tests where positive results require careful explanation about false positive rates, follow-up testing needs, and actual risk levels. AI systems often struggle to communicate this uncertainty effectively.

The importance of specialized health AI platforms

Given these limitations, the solution isn't to avoid AI entirely but to use specialized platforms designed specifically for health data analysis. These platforms address many of the limitations of general-purpose AI by incorporating medical expertise, proper security measures, and comprehensive tracking capabilities.

Purpose-built health AI systems can maintain your complete testing history, track trends over time, and provide interpretations based on your individual baseline rather than just population averages. They also ensure proper data security and compliance with healthcare regulations. For those serious about understanding their biomarkers and optimizing their health, specialized platforms like SiPhox Health's AI assistant Sai offer a more reliable and comprehensive approach to lab result interpretation.

When AI analysis falls short: Real-world examples

Complex hormonal patterns

Hormonal testing provides a clear example of where AI limitations become apparent. Hormone levels fluctuate throughout the day, across menstrual cycles, and with age. A testosterone level that's normal for a 60-year-old might indicate a problem in a 25-year-old. Without considering timing, age, and symptoms, AI interpretation of hormone tests can be misleading.

Furthermore, hormones work in complex feedback loops. Interpreting thyroid function requires looking at TSH, Free T4, and Free T3 together, understanding their relationships, and considering symptoms. General AI tools often analyze each marker independently, missing these crucial interactions.

Nutritional deficiencies and optimal ranges

Another area where AI struggles is distinguishing between 'normal' and 'optimal' ranges. Many nutritional markers like vitamin D, B12, or ferritin have wide normal ranges, but optimal levels for health and performance may be much narrower. AI systems trained on diagnostic criteria might miss opportunities for optimization that could significantly impact quality of life.

Individual needs also vary based on lifestyle, diet, and health goals. An athlete might need higher iron stores than a sedentary person, and someone with absorption issues might require different B12 targets. These nuances are often lost in automated AI analysis.

Making informed decisions about AI health tools

Understanding these limitations doesn't mean AI has no place in health management. Instead, it highlights the importance of choosing the right tools and using them appropriately. When evaluating AI platforms for lab analysis, consider whether they offer comprehensive tracking, medical oversight, and personalized insights based on your complete health picture.

The future of AI in healthcare is bright, but current limitations mean that the most effective approach combines AI capabilities with human expertise and proper medical context. By choosing specialized platforms designed for health optimization and maintaining realistic expectations about what AI can and cannot do, you can leverage technology to better understand your health without falling into the pitfalls of oversimplified or inaccurate interpretations.

For those looking to take control of their health data, the SiPhox Health platform offers a free service to upload and analyze past lab results with AI-powered insights designed specifically for biomarker interpretation. This specialized approach addresses many of the limitations found in general-purpose AI tools while providing the convenience and accessibility that makes regular health monitoring practical and actionable.

References

  1. Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44-56.[Link][DOI]
  2. Beam, A. L., & Kohane, I. S. (2018). Big data and machine learning in health care. JAMA, 319(13), 1317-1318.[Link][DOI]
  3. Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347-1358.[Link][DOI]
  4. Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447-453.[Link][DOI]
  5. Liu, X., Faes, L., Kale, A. U., Wagner, S. K., Fu, D. J., Bruynseels, A., ... & Denniston, A. K. (2019). A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. The Lancet Digital Health, 1(6), e271-e297.[Link][DOI]
  6. Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., ... & Dean, J. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24-29.[Link][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my biomarkers at home?

You can test your biomarkers at home with SiPhox Health's Core Health Program, which includes comprehensive testing of metabolic, cardiovascular, and hormonal markers. The program provides lab-quality results with AI-powered insights designed specifically for health optimization.

What's the difference between general AI and specialized health AI?

General AI tools like ChatGPT lack medical context, cannot track trends over time, and use generic reference ranges. Specialized health AI platforms are designed specifically for medical data, incorporate your complete health history, ensure data security compliance, and provide personalized insights based on your individual baseline and health goals.

Can AI replace my doctor for interpreting lab results?

No, AI cannot replace medical professionals for diagnosis or treatment decisions. AI tools should be used for educational purposes and to help you better understand your results, but any concerning findings or health decisions should always be discussed with a qualified healthcare provider who can consider your complete medical context.

Is it safe to upload my lab results to AI platforms?

Safety depends on the platform. General-purpose AI tools may not have proper security measures for sensitive health data. Specialized health platforms like SiPhox Health's free upload service are designed with HIPAA compliance and proper data protection specifically for medical information.

How can I get the most accurate AI analysis of my lab results?

For the most accurate analysis, use Sai, SiPhox Health's AI health optimization expert, which is specifically designed for biomarker interpretation. Provide complete information including your age, sex, medications, and health goals. Track results over time to identify trends, and always verify AI insights with healthcare professionals for medical decisions.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details